Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment.

Tamura Y, Suda T, Arii S, Sata M, Moriyasu F, Imamura H, Kawasaki S, Izumi N, Takayama T, Kokudo N, Yamamoto M, Iijima H, Aoyagi Y.

Dig Dis Sci. 2013 Aug;58(8):2406-12. doi: 10.1007/s10620-013-2661-6. Epub 2013 Apr 18.

PMID:
23595518
[PubMed - indexed for MEDLINE]
2.

Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations.

Morimoto M, Numata K, Nozaki A, Kondo M, Moriya S, Taguri M, Morita S, Konno M, Sugo A, Miyajima E, Maeda S, Tanaka K.

Int J Clin Oncol. 2012 Aug;17(4):373-9. doi: 10.1007/s10147-011-0306-3. Epub 2011 Aug 17.

PMID:
21847534
[PubMed - indexed for MEDLINE]
3.

Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.

Choi JY, Jung SW, Kim HY, Kim M, Kim Y, Kim DG, Oh EJ.

World J Gastroenterol. 2013 Jan 21;19(3):339-46. doi: 10.3748/wjg.v19.i3.339.

PMID:
23372355
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.

Toyoda H, Kumada T, Kaneoka Y, Osaki Y, Kimura T, Arimoto A, Oka H, Yamazaki O, Manabe T, Urano F, Chung H, Kudo M, Matsunaga T.

J Hepatol. 2008 Aug;49(2):223-32. doi: 10.1016/j.jhep.2008.04.013. Epub 2008 May 23.

PMID:
18571271
[PubMed - indexed for MEDLINE]
5.

Tumor marker levels before and after curative treatment of hepatocellular carcinoma as predictors of patient survival.

Nanashima A, Taura N, Abo T, Ichikawa T, Sakamoto I, Nagayasu T, Nakao K.

Dig Dis Sci. 2011 Oct;56(10):3086-100. doi: 10.1007/s10620-011-1796-6. Epub 2011 Jun 25.

PMID:
21706206
[PubMed - indexed for MEDLINE]
6.

Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.

Hadziyannis E, Sialevris K, Georgiou A, Koskinas J.

Oncol Rep. 2013 Feb;29(2):835-9. doi: 10.3892/or.2012.2147. Epub 2012 Nov 20.

PMID:
23174906
[PubMed - indexed for MEDLINE]
7.

Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.

Tateishi R, Shiina S, Yoshida H, Teratani T, Obi S, Yamashiki N, Yoshida H, Akamatsu M, Kawabe T, Omata M.

Hepatology. 2006 Dec;44(6):1518-27.

PMID:
17133456
[PubMed - indexed for MEDLINE]
8.

Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.

Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Tameda Y, Nakano T.

Int J Mol Med. 2002 Mar;9(3):245-50.

PMID:
11836630
[PubMed - indexed for MEDLINE]
9.

Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment.

Tamura Y, Igarashi M, Suda T, Wakai T, Shirai Y, Umemura T, Tanaka E, Kakizaki S, Takagi H, Hiasa Y, Onji M, Aoyagi Y.

Dig Dis Sci. 2010 Jul;55(7):2095-101. doi: 10.1007/s10620-009-0954-6.

PMID:
19731025
[PubMed - indexed for MEDLINE]
10.

Clinical advantage of highly sensitive on-chip immunoassay for fucosylated fraction of alpha-fetoprotein in patients with hepatocellular carcinoma.

Tamura Y, Igarashi M, Kawai H, Suda T, Satomura S, Aoyagi Y.

Dig Dis Sci. 2010 Dec;55(12):3576-83. doi: 10.1007/s10620-010-1222-5. Epub 2010 Apr 21.

PMID:
20407827
[PubMed - indexed for MEDLINE]
11.

Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.

Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, Kanke F, Schwartz ME, Sherman M.

Clin Gastroenterol Hepatol. 2009 Jan;7(1):104-13. doi: 10.1016/j.cgh.2008.08.041. Epub 2008 Sep 17.

PMID:
18849011
[PubMed - indexed for MEDLINE]
12.

A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.

Shimauchi Y, Tanaka M, Kuromatsu R, Ogata R, Tateishi Y, Itano S, Ono N, Yutani S, Nagamatsu H, Matsugaki S, Yamasaki S, Tanikawa K, Sata M.

Oncol Rep. 2000 Mar-Apr;7(2):249-56.

PMID:
10671666
[PubMed - indexed for MEDLINE]
13.

Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.

Zhang XF, Lai EC, Kang XY, Qian HH, Zhou YM, Shi LH, Shen F, Yang YF, Zhang Y, Lau WY, Wu MC, Yin ZF.

Ann Surg Oncol. 2011 Aug;18(8):2218-23. doi: 10.1245/s10434-011-1613-7. Epub 2011 Feb 20.

PMID:
21336512
[PubMed - indexed for MEDLINE]
14.

Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.

Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N.

Ann Surg Oncol. 2009 Oct;16(10):2795-804. doi: 10.1245/s10434-009-0618-y. Epub 2009 Aug 11.

PMID:
19669841
[PubMed - indexed for MEDLINE]
15.

Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma.

Nobuoka D, Kato Y, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kinoshita T, Nakatsura T.

Oncol Rep. 2010 Aug;24(2):521-8.

PMID:
20596642
[PubMed - indexed for MEDLINE]
16.

Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.

Zhang XF, Yin ZF, Wang K, Zhang ZQ, Qian HH, Shi LH.

Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):618-23.

PMID:
23232633
[PubMed - indexed for MEDLINE]
Free Article
17.

Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.

Nouso K, Kobayashi Y, Nakamura S, Kobayashi S, Takayama H, Toshimori J, Kuwaki K, Hagihara H, Onishi H, Miyake Y, Ikeda F, Shiraha H, Takaki A, Iwasaki Y, Kobashi H, Yamamoto K.

J Gastroenterol Hepatol. 2011 Jul;26(7):1195-200. doi: 10.1111/j.1440-1746.2011.06720.x.

PMID:
21410750
[PubMed - indexed for MEDLINE]
18.

Tumor markers after radiofrequency ablation therapy for hepatocellular carcinoma.

Ogawa C, Kudo M, Minami Y, Chung H, Kawasaki T.

Hepatogastroenterology. 2008 Jul-Aug;55(85):1454-7.

PMID:
18795710
[PubMed - indexed for MEDLINE]
19.

Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.

Hayashi M, Shimizu T, Hirokawa F, Inoue Y, Komeda K, Asakuma M, Miyamoto Y, Takeshita A, Shibayama Y, Tanigawa N.

Am Surg. 2011 May;77(5):572-8.

PMID:
21679590
[PubMed - indexed for MEDLINE]
20.

Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma.

Khien VV, Mao HV, Chinh TT, Ha PT, Bang MH, Lac BV, Hop TV, Tuan NA, Don LV, Taketa K, Satomura S.

Int J Biol Markers. 2001 Apr-Jun;16(2):105-11.

PMID:
11471892
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk